Fiera Capital Corp Amgen Inc Transaction History

Fiera Capital Corp

$30.4 Billion
Q2 2024

A detailed history of Fiera Capital Corp transactions in Amgen Inc stock. As of the latest transaction made, Fiera Capital Corp holds 1,992 shares of AMGN stock, worth $628,555. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,992

Previous 1,992 -0.0%

Holding current value

$628,555

Previous $622,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$262.75 - $319.31 $229,380 - $278,757	-873 Reduced 30.47%	1,992 $622,000
Q1 2024 Aug 22, 2024	BUY	$268.87 - $324.56 $234,723 - $283,340	873 Added 43.83%	2,865 $814,000
Q1 2024 May 01, 2024	SELL	$268.87 - $324.56 $12,099 - $14,605	-45 Reduced 1.55%	2,865 $814,000
Q4 2023 Aug 22, 2024	BUY	$255.7 - $288.46 $77,221 - $87,114	302 Added 11.58%	2,910 $838,000
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $77,221 - $87,114	302 Added 11.58%	2,910 $838,000
Q3 2023 Aug 22, 2024	BUY	$218.65 - $271.46 $134,688 - $167,219	616 Added 30.92%	2,608 $700,000
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $162,238 - $201,423	-742 Reduced 22.15%	2,608 $700,000
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $73,494 - $86,905	-343 Reduced 9.29%	3,350 $743,000
Q1 2023 Apr 26, 2023	BUY	$225.79 - $275.2 $45,835 - $55,865	203 Added 5.82%	3,693 $892,000
Q4 2022 Feb 08, 2023	SELL	$229.03 - $291.01 $2.28 Million - $2.9 Million	-9,972 Reduced 74.08%	3,490 $916,000
Q3 2022 Nov 03, 2022	SELL	$224.46 - $253.15 $70,929 - $79,995	-316 Reduced 2.29%	13,462 $3.03 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $2.18 Million - $2.42 Million	9,441 Added 217.69%	13,778 $3.35 Million
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $47,143 - $52,152	-215 Reduced 4.72%	4,337 $1.05 Million
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $63,243 - $72,376	318 Added 7.51%	4,552 $1.02 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $113,776 - $133,303	536 Added 14.49%	4,234 $900,000
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $61,665 - $68,412	-264 Reduced 6.66%	3,698 $901,000
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $56.9 Million - $66.3 Million	-256,252 Reduced 98.48%	3,962 $1.24 Million
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $666,234 - $793,365	-3,079 Reduced 1.17%	260,214 $59.8 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $321,939 - $358,023	-1,372 Reduced 0.52%	263,293 $66.9 Million
Q2 2020 Aug 07, 2020	BUY	$197.81 - $242.74 $571,275 - $701,033	2,888 Added 1.1%	264,665 $62.4 Million
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $4.01 Million - $5.31 Million	21,977 Added 9.16%	261,777 $53.1 Million
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $390,529 - $501,964	-2,064 Reduced 0.85%	239,800 $57.8 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $564,290 - $676,137	3,241 Added 1.36%	241,864 $46.8 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $547,442 - $641,726	-3,284 Reduced 1.36%	238,623 $44 Million
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $498,839 - $562,301	2,758 Added 1.15%	241,907 $46 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $1.12 Million - $1.31 Million	6,294 Added 2.7%	239,149 $46.6 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $513,623 - $579,043	-2,772 Reduced 1.18%	232,855 $48.3 Million
Q2 2018 Aug 02, 2018	SELL	$166.05 - $186.51 $247,414 - $277,899	-1,490 Reduced 0.63%	235,627 $43.5 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $2.78 Million - $3.25 Million	-16,417 Reduced 6.48%	237,117 $40.4 Million
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $1.31 Million - $1.46 Million	-7,766 Reduced 2.97%	253,534 $44.1 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $43.7 Million - $49.9 Million	261,300	261,300 $48.7 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.

Account

Fiera Capital Corp Amgen Inc Transaction History